Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.

When you think of health care, what do you picture? Many of us see doctors in white coats and nurses wearing scrubs, but we don’t think of the people behind the scenes who ensure everything runs ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Anticipating a 35% CAGR in 2025, Hims & Hers is poised for substantial growth. Read why I maintain my strong buy rating on ...

AAP on Wednesday alleged that certain "corrupt" officials were trying to push a "flawed" hospital information management system (HIMS), which, it claimed, lacked crucial modules for mohalla clinics, ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Hims & Hers is a fantastic value despite its high on-the-surface P/E ratio and valuation metrics. Click here to read why HIMS ...

In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against the other hair care stocks. According to Fortune Business Insights, in 2023, the hair care ...

While it can affect your confidence, Hims has a solution to restore both your hair and the way you feel about how you look. The provider offers a number of prescription and over-the-counter hair ...

The space is dominated by manufacturers like Zenbooth and Room, which sell soundproof booths to do just that. [Image: Herman Miller] Herman Miller designed its Bay Work Pod to have an elevated look.

Hims & Hers Health is a telehealth company known for offering compounded alternatives to popular GLP-1 weight-loss treatments. Its shares have soared over 120% since August 2023. Also Read ...